Jess Rydstrom litigates complex civil cases, with an emphasis on commercial and patent litigation and products liability defense. Jess has tried cases in federal and state courts, in arbitration, and across a variety of industries.
Jess has represented corporations, professional firms, and individuals in a broad range of cases, at both the trial and appellate levels, in arbitration proceedings, and in regulatory and congressional investigations. She has experience in a range of substantive areas, including commercial disputes, products liability, intellectual property and licensing litigation, legal and accounting malpractice, and qui tam actions.
Jess recently joined the adjunct faculty at Georgetown University Law Center, where she teaches Trial Practice. She is a member of the firm’s Women’s Initiative and is the Chair of the Hiring Committee.
A native Californian, Jess graduated with honors from Duke Law, where she was Executive Editor of the Duke Law Journal and a member of the Moot Court Board. She joined the firm in 2009 after clerking for the Honorable Catherine C. Blake on the District of Maryland. Before law school, Jess worked as a legislative aide to Congresswoman Zoe Lofgren.
- In 2020, trial counsel for a pharmaceutical company in a contract dispute.
- In 2019, trial counsel in a successful arbitration over the amount of royalties owed under a license agreement.
- In 2019, counsel in a trial-set personal injury products liability case in state court in California.
- In 2018, trial counsel for a major telecommunications company in a confidential commercial arbitration with FCC licensees.
- In 2016, trial counsel for a pharmaceutical company in patent litigation in the Northern District of California.
- Trial counsel for a biopharmaceutical company in contract dispute regarding intellectual property and joint venture agreement in state court.
- Trial counsel for a pharmaceutical company in Hatch-Waxman litigation in the District of Delaware.
- Representation of a national accounting firm in the defense of multiple audit malpractice actions, including investigations by the Securities and Exchange Commission, the Department of Justice, the Commodity Futures Trading Commission, and state agencies.
- Representation of a specialty pharmacy in qui tam action involving allegations under the Anti-Kickback Statute.